Skip to Main Content

INFORMATION FOR

Amin Nassar, MD

Clinical Fellow

Biography

Amin Nassar, M.D., is a hematology/oncology fellow at Yale University. He received his medical degree from the American University of Beirut and completed residency at Brigham and Women’s Hospital. Dr. Nassar also pursued a two-year postdoctoral training at Brigham and Women’s Hospital where he worked under the mentorship of Professors Dr. David Kwiatkowski, Dr. Toni Choueiri, and Dr. Matthew Freedman at Harvard Medical School. His research focuses on the identification of genomic biomarkers across ancestral populations with cancer. Dr. Nassar currently serves on the editorial board of “Molecular biology reports”, “Translational oncology”, and “Frontiers in Oncology”. He is also one of the Associate Guest editors for the journal “Frontiers in Oncology” and is part of the editorial team for the Elsevier Practice Update Bladder Cancer Center of Excellence. Dr. Nassar is interested in a career as a physician-scientist with a clinical focus in thoracic oncology.

Education & Training

  • Internal Medicine
    Brigham and Women's Hospital (2022)
  • MD
    American University of Beirut (2017)

Activities

  • Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes to immune checkpoint inhibitors
    Orlando, FL, United States 2023
    AACR Annual Meeting 2023

Honors & Recognition

AwardDate
ASH Achievement Award2022
Alpha Omega Alpha2016

Professional Service

OrganizationRoleDate
Cancer CellReviewer2023 - Present
Clinical EpigeneticsReviewer2022 - Present
GastroenterologyReviewer2022 - Present
Journal of Clinical MedicineGuest Editor2022 - Present
Frontiers in OncologyAssociate Editor2022 - Present
Journal for ImmunoTherapy of CancerReviewer2022 - Present
Future OncologyReviewer2021 - Present
Clinical Genitourinary cancerReviewer2021 - Present
Journal of Translational Medicine Editorial OfficeReviewer2020 - Present
Translational OncologyEditorial Board Member2020 - Present
Therapeutic Advances in Medical OncologyReviewer2020 - Present
Molecular Biology ReportsEditorial Board Member2017 - Present